Revenue

A breakthrough 'pap smear for the pancreas' that detects early cancer has secured major funding, offering new hope against one of the deadliest diseases.

MBX Biosciences prepares for the Jefferies conference, with investors eyeing updates on its late-stage hypoparathyroidism drug and promising obesity portfolio.

In an unprecedented move, top executives from competing Washington wineries are joining forces. Can their 'One Voice' rewrite the state's future on the national stage?

Struggling with losses, Nocera is betting its future on a $300M pivot into five of the world's most competitive tech sectors. Can it succeed?

A new report shows hospitals in a federal drug discount program provide less charity care than others, fueling calls for urgent federal reforms.

A new campaign asks global citizens to turn Mandela Day's 67 minutes into a year of sustained support for South Africa's most vulnerable children.

Colombia invests $260M to regain vaccine independence through a landmark tech transfer deal with South Korea's SK bioscience. A new chapter begins.

Amid promising safety signals, Kazia Therapeutics expands its trial for paxalisib in TNBC, a strategic move offering new hope for a hard-to-treat cancer.

A new telehealth platform offers prescription-only CBD, navigating a major regulatory shift that will reshape the entire cannabis industry. Here's what's next.

Cannabis giant Curaleaf is rolling the dice with a reverse stock split, aiming for a coveted spot on a major U.S. exchange ahead of federal rescheduling.

Tribe Property Technologies reports its second straight quarter of positive adjusted EBITDA, signaling a shift toward sustainable growth and tech-led consolidation.

With over 28,000 attendees, Toronto's Living Luxe Design Show redefined luxury, focusing on wellness, experience, and personalization over mere possession.

With strong clinical data for its Dayspring system, Koya Medical is pitching to investors to fund the next phase of growth for its patient-centered tech.

Growth equity firm AVANT BIO adds biomanufacturing legends Maik Jornitz and Lukas Utiger, signaling a shift toward deep operational support for its startups.

London's Upp.ai joins an elite list of UK AI innovators, validating its platform that is already revolutionizing ad spend for major retailers like B&Q.

AI data firm Hyperscale Data nears 700 Bitcoin in its treasury, a bold move to blend high-tech infrastructure with digital assets amid a major corporate pivot.

Amid high valuations, ICHAM's new fund uses options and sector rotation to offer income and returns for sophisticated investors in a challenging market.

With overwhelming shareholder approval, Savanna Capital is set to become North American Silver Corp., targeting a promising Mexican silver project.

A new advisory firm aims to simplify complex financial management for Sanibel's entrepreneurs by combining tax, valuation, and strategic CFO services.

Studies reveal an AI platform slashes cancer patient hospitalizations by up to 51% and saves millions, heralding a new era of remote oncology care.